定量钠成像与胶质瘤:一项可行性研究
本研究在3T磁共振上使用自制1H/23Na头线圈对8例初治胶质瘤患者进行钠MRI定量成像,生成伪细胞内钠浓度、伪细胞外体积分数、表观细胞内钠浓度和表观总钠浓度图。结果显示,与对侧正常表现白质相比,实体肿瘤的表观总钠浓度和伪细胞外体积分数显著升高,表观细胞内钠浓度显著降低。
要点
- 定量钠MRI可在胶质瘤患者中完成,并生成多种钠浓度相关参数图。
- 与对侧正常表现白质相比,实体肿瘤的表观总钠浓度和伪细胞外体积分数显著升高。
- 实体肿瘤的表观细胞内钠浓度较对侧正常表现白质显著降低。
核心结论
- 定量钠测量可在胶质瘤患者中实施,并进一步证明胶质瘤中总钠浓度和细胞外体积分数升高。
研究设计与样本
- 可行性研究,纳入8例初治胶质瘤患者,在3T磁共振上使用自制1H/23Na头线圈扫描,生成伪细胞内钠浓度(C1)、伪细胞外体积分数(α2)、表观细胞内钠浓度(aISC)和表观总钠浓度(aTSC)图;测量感兴趣区包括对侧正常表现壳核、对侧正常表现白质(NAWM)和实体肿瘤区(T2-FLAIR异常区域,排除极可能为水肿、囊肿或坏死的区域);采用配对样本t检验比较NAWM与壳核及NAWM与实体肿瘤。
关键影像表现/征象
- 与对侧正常表现白质相比,对侧正常表现壳核的表观总钠浓度、表观细胞内钠浓度和伪细胞内钠浓度显著更高(p < 0.001),伪细胞外体积分数亦显著更高(p = 0.002)。
- 与对侧正常表现白质相比,全部实体肿瘤的平均值显示表观总钠浓度和伪细胞外体积分数显著更高(p < 0.001),表观细胞内钠浓度显著更低(p = 0.02),且每位患者均如此。
- 实体肿瘤与对侧正常表现白质之间的伪细胞内钠浓度无显著差异(p = 0.19)。
诊断标准与关键数值
- 表观总钠浓度(aTSC)和伪细胞外体积分数(α2)在实体肿瘤中较对侧正常表现白质显著升高(p < 0.001)。
- 表观细胞内钠浓度(aISC)在实体肿瘤中较对侧正常表现白质显著降低(p = 0.02)。
- 伪细胞内钠浓度(C1)在实体肿瘤与对侧正常表现白质间无显著差异(p = 0.19)。
临床应用与阅片要点
- 定量钠MRI生成的表观总钠浓度和伪细胞外体积分数图可能有助于评估胶质瘤。
- 实体肿瘤区定义为T2-FLAIR异常区域,测量时排除了极可能为水肿、囊肿或坏死的区域。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Recent advances in sodium brain MRI have allowed for increased signal-to-noise ratio, faster imaging, and the ability of differentiating intracellular from extracellular sodium concentration, opening a new window of opportunity for clinical application. In gliomas, there are significant alterations in sodium metabolism, including increase in the total sodium concentration and extracellular volume fraction. The purpose of this study is to assess the feasibility of using sodium MRI quantitative measurements to evaluate gliomas.
METHODS: Eight patients with treatment-naïve gliomas were scanned at 3 T with a homemade 1H/23Na head coil, generating maps of pseudo-intracellular sodium concentration (C1), pseudo-extracellular volume fraction (α2), apparent intracellular sodium concentration (aISC), and apparent total sodium concentration (aTSC). Measurements were made within the contralateral normal-appearing putamen, contralateral normal-appearing white matter (NAWM), and solid tumor regions (area of T2-FLAIR abnormality, excluding highly likely areas of edema, cysts, or necrosis). Paired samples t test were performed comparing NAWM and putamen and between NAWM and solid tumor.
RESULTS: The normal-appearing putamen demonstrated significantly higher values for aTSC, aISC, C1 (p < 0.001), and α2 (p = 0.002) when compared to those of NAWM. The mean average of all solid tumors, when compared to that of NAWM, demonstrated significantly higher values of aTSC and α2 (p < 0.001), and significantly lower values of aISC (p = 0.02) for each patient. There was no significant difference between the values of C1 (p = 0.19).
CONCLUSION: Quantitative sodium measurements can be done in glioma patients and also has provided further evidence that total sodium and extracellular volume fraction are increased in gliomas.
引用
- Nunes Neto LP, Madelin G, Sood TP, et al. Quantitative sodium imaging and gliomas: a feasibility study. Neuroradiology. 2018. PMID: 29862413. doi:10.1007/s00234-018-2041-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。